Boberg KM - Search Results

1

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Næss S, Thomsen I, Mayr G, König IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricaño-Ponce I, van Heel D, Björnsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouillères O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M; UK-PSCSC Consortium; Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Färkkilä M, Dale AM, Chapman RW, Lazaridis KN; International PSC Study Group; Franke A, Anderson CA, Karlsen TH; International IBD Genetics Consortium. Liu JZ, et al. Among authors: boberg km. Nat Genet. 2013 Jun;45(6):670-5. doi: 10.1038/ng.2616. Epub 2013 Apr 21. Nat Genet. 2013. PMID: 23603763 Free PMC article.

2

Etiology and pathogenesis in primary sclerosing cholangitis.

Boberg KM, Lundin KE, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol Suppl. 1994;204:47-58. doi: 10.3109/00365529409103625. Scand J Gastroenterol Suppl. 1994. PMID: 7824878 Review.

3

Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis.

Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E. Boberg KM, et al. Scand J Gastroenterol. 1994 Aug;29(8):744-52. doi: 10.3109/00365529409092504. Scand J Gastroenterol. 1994. PMID: 7973436

4

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.

Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. Boberg KM, et al. Hepatology. 1996 Jun;23(6):1369-76. doi: 10.1002/hep.510230612. Hepatology. 1996. PMID: 8675153

5

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.

Bansi DS, Bauducci M, Bergqvist A, Boberg K, Broome U, Chapman R, Fleming K, Jorgensen R, Lindor K, Rosina F, Schrumpf E. Bansi DS, et al. Eur J Gastroenterol Hepatol. 1997 Jun;9(6):575-80. doi: 10.1097/00042737-199706000-00005. Eur J Gastroenterol Hepatol. 1997. PMID: 9222729 Clinical Trial.

6

[Treatment of cholestatic liver diseases with ursodeoxycholic acid].

Boberg KM, Schrumpf E. Boberg KM, et al. Tidsskr Nor Laegeforen. 1997 Sep 30;117(23):3370-3. Tidsskr Nor Laegeforen. 1997. PMID: 9411890 Review. Norwegian.

7

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.

Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E. Spurkland A, et al. Among authors: boberg km. Tissue Antigens. 1999 May;53(5):459-69. doi: 10.1034/j.1399-0039.1999.530502.x. Tissue Antigens. 1999. PMID: 10372541

8

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.

Boberg KM, Schrumpf E, Bergquist A, Broomé U, Pares A, Remotti H, Schjölberg A, Spurkland A, Clausen OP. Boberg KM, et al. J Hepatol. 2000 Mar;32(3):374-80. doi: 10.1016/s0168-8278(00)80386-4. J Hepatol. 2000. PMID: 10735605

9

Primary sclerosing cholangitis: challenges of a new millenium.

Schrumpf E, Boberg KM. Schrumpf E, et al. Among authors: boberg km. Dig Liver Dis. 2000 Dec;32(9):753-5. doi: 10.1016/s1590-8658(00)80350-3. Dig Liver Dis. 2000. PMID: 11215553 Review. No abstract available.

10

Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis.

Fleming KA, Boberg KM, Glaumann H, Bergquist A, Smith D, Clausen OP. Fleming KA, et al. Among authors: boberg km. J Hepatol. 2001 Mar;34(3):360-5. doi: 10.1016/s0168-8278(00)00034-9. J Hepatol. 2001. PMID: 11322195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page